Althof, Zachary W.
Gerard, Sarah E.
Eskandari, Ali
Galizia, Mauricio S.
Hoffman, Eric A.
Reinhardt, Joseph M.
Funding for this research was provided by:
National Institutes of Health (T32 HL144461, T32 HL144461, T32 HL144461, HL142625, HL142625)
Article History
Received: 1 February 2023
Accepted: 24 August 2023
First Online: 29 August 2023
Competing interests
: Drs. Hoffman and Reinhardt are shareholders in VIDA Diagnostics, Inc. Zachary Althof was formerly employed by VIDA Diagnostics, Inc. Drs. Gerard and Reinhardt have US patent 11,475,562 on the FissureNet fissure segmentation method. Drs. Galizia and Eskandari do not have any competing interests.